Suppr超能文献

使用抗细胞角蛋白抗体AE1/AE3检测Dukes' A期和B期结直肠癌中的淋巴结微转移。

Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.

作者信息

Zhou Zhi-Wei, Rieger Nick, Ruszkiewicz Andrew, Wang Guo-Qiang, Wan De-Sen

机构信息

Department of Abdominal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China.

出版信息

World J Gastroenterol. 2005 Jun 21;11(23):3640-3. doi: 10.3748/wjg.v11.i23.3640.

Abstract

AIM

To detect lymph nodes micrometastases and analyze its correlation with clinicopathological parameters in Dukes' A and B colorectal cancer patients.

METHODS

One hundred and fourteen patients with colorectal cancer (Dukes' A 16; Dukes' B 98) undergoing curative operation without histological lymph nodes metastases were studied between 2001 and 2003. A total of 2,481 lymph nodes were analyzed using monoclonal cytokeratin antibody AE1/AE3 (DAKO, Carpinteria, CA) for immunohistochemistry.

RESULTS

In total, 33 (29%) patients were positive for cancer cell by immunohistochemistry. In 31 (94%) patients of them positive nodes showed single tumor cell or small groups of tumor cells; and tumor deposits measuring 0.2 and 0.37 mm in diameter in another 2 (6%) patients. Micrometastases were mainly located in the subcapsular sinus or paracortical sinus. There was no correlation between the positive lymph nodes and gender, age, tumor site, tumor size, histological type, histological grade, invasion depth, Dukes' staging and microsatellite instability (P>0.05).

CONCLUSION

Our findings suggest that immunohistochemical technique using monoclonal cytokeratin antibody AE1/AE3 may be a sensitive and reliable method for detecting lymph nodes micrometastases in Dukes' A and B colorectal cancer. The clinical significance of lymph nodes micrometastases is still not confirmed.

摘要

目的

检测Dukes' A期和B期结直肠癌患者的淋巴结微转移,并分析其与临床病理参数的相关性。

方法

对2001年至2003年间114例接受根治性手术且无组织学淋巴结转移的结直肠癌患者(Dukes' A期16例;Dukes' B期98例)进行研究。使用单克隆细胞角蛋白抗体AE1/AE3(DAKO,加利福尼亚州卡平特里亚)进行免疫组织化学分析,共分析了2481个淋巴结。

结果

免疫组织化学检测显示,共有33例(29%)患者癌细胞呈阳性。其中31例(94%)患者的阳性淋巴结显示单个肿瘤细胞或小簇肿瘤细胞;另外2例(6%)患者的肿瘤沉积物直径分别为0.2和0.37 mm。微转移主要位于被膜下窦或副皮质窦。阳性淋巴结与性别、年龄、肿瘤部位、肿瘤大小、组织学类型、组织学分级、浸润深度、Dukes分期和微卫星不稳定性之间均无相关性(P>0.05)。

结论

我们的研究结果表明,使用单克隆细胞角蛋白抗体AE1/AE3的免疫组织化学技术可能是检测Dukes' A期和B期结直肠癌淋巴结微转移的一种敏感且可靠方法。淋巴结微转移的临床意义仍未得到证实。

相似文献

1
Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.
World J Gastroenterol. 2005 Jun 21;11(23):3640-3. doi: 10.3748/wjg.v11.i23.3640.

引用本文的文献

1
Identification of novel drugs to target dormant micrometastases.
BMC Cancer. 2015 May 14;15:404. doi: 10.1186/s12885-015-1409-4.

本文引用的文献

7
Micrometastases and survival in stage II colorectal cancer.
N Engl J Med. 1998 Jul 23;339(4):223-8. doi: 10.1056/NEJM199807233390403.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验